Drug
Genvoya
Genvoya: highest development phase Phase 3, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Genvoya NCT02998320 | Phase 3 | HIV Risk |
Latest
No recent events.
Follow Genvoya on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.